Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
3.810
0.00 (0.00%)
Aug 14, 2025, 12:50 PM - Market open
Evotec SE Revenue
Evotec SE had revenue of 171.24M EUR in the quarter ending June 30, 2025, a decrease of -5.98%. This brings the company's revenue in the last twelve months to 777.33M, down -1.41% year-over-year. In the year 2024, Evotec SE had annual revenue of 796.97M with 1.99% growth.
Revenue (ttm)
777.33M EUR
Revenue Growth
-1.41%
P/S Ratio
1.48
Revenue / Employee
163,994 EUR
Employees
4,740
Market Cap
1.35B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
| Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
| Dec 31, 2022 | 751.45M | 133.41M | 21.59% |
| Dec 31, 2021 | 618.03M | 117.11M | 23.38% |
| Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
EVO News
- 23 hours ago - Evotec SE (EVO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Evotec SE Reports H1 2025 Results: Strong Progress on Strategy Execution - Accesswire
- 8 days ago - Evotec SE to announce first half-year results 2025 on 13 August 2025 - Accesswire
- 15 days ago - Evotec SE and Sandoz AG Planning Potential Sale of Just - Evotec Biologics Toulouse Site - Accesswire
- 15 days ago - Evotec and Sandoz Evolve their Strategic Partnership and Agree on Potential Sale of Just - Evotec Biologics Toulouse Site - Accesswire
- 22 days ago - Evotec: Recovery Seems To Be Beginning - Seeking Alpha
- 24 days ago - Evotec, Webull And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
- 24 days ago - Evotec Adjusts Revenue Guidance and Confirms Profit Guidance Anticipating a More Profitable Revenue Mix - Accesswire